Developed by Karuna Therapeutics, which was subsequently acquired by Bristol Myers Squibb, the drug works in an entirely ...

The US Food and Drug Administration (FDA) has just approved a new drug for the treatment of schizophrenia. Marketed under the ...

A study has uncovered a mechanism in the brain that could effectively broaden the understanding of sleep disorders and their ...

Neurotransmitters are chemical messengers that have excitatory, inhibitory, and modulatory actions. Learn what they are and ...

Melatonin MT1 receptor plays a crucial role in regulating REM sleep. A novel drug could extend REM sleep without negative ...

A recent study from the Research Institute at McGill University Health Center may improve the treatment of sleep disorders ...

Endogenous adenosine, a bioenergetic molecule, has potent neuroprotective and neuromodulatory actions and regulates the release of various neurotransmitters involved in the phenomena of drug ...

Obesity is common worldwide and continues to increase in prevalence. GLP-1 receptor agonists were developed for the treatment of diabetes but have revolutionised the treatment of obesity, consistently ...

Naltrexone is an opioid receptor antagonist that has been shown ... Acamprosate modulates glutamate neurotransmitter pathways through an unknown mechanism to reduce alcohol withdrawal ...